Harry R. Maxon

7.3k citations

67 papers · 4.4k indexed · 1 hit paper · h-index 30

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Radiation Dose and Imaging
- Medical Imaging Techniques and Applications

Papers in

Endocrinology, Diabetes and Metabolism 29
- Thyroid Cancer Diagnosis and Treatment 24
- Thyroid Disorders and Treatments 13
Radiology, Nuclear Medicine and Imaging 37
- Radiopharmaceutical Chemistry and Applications 18
- Radiation Dose and Imaging 13
- Medical Imaging Techniques and Applications 12

Co-authors: James G. Kereiakes Howard S. Smith Stephen Thomas Matthew Sperling Vicki Hertzberg Douglas S. Ross Bryan R. Haugen James D. Brierley
Journals: Thyroid (8 papers)Radiology (7 papers)Clinical Chemistry (6 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Nuclear Medicine and Biology (2 papers)
Partner nations: United States Canada China

In The Last Decade

Harry R. Maxon

65 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy 2006 · 507 citations

Peers

Countries citing papers authored by Harry R. Maxon

Since Specialization

Citations

This map shows the geographic impact of Harry R. Maxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry R. Maxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry R. Maxon more than expected).

Fields of papers citing papers by Harry R. Maxon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry R. Maxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry R. Maxon. The network helps show where Harry R. Maxon may publish in the future.

Co-authors

The 25 scholars most cited alongside Harry R. Maxon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harry R. Maxon Line = papers co-authored together Harry R. Maxon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence Thyroid ·Ngwe Yin, Steven I. Sherman, Youngju Pak, Danielle R. Litofsky, Andrew G. Gianoukakis, (unknown), Kenneth B. Ain, S. Thomas Bigos, James D. Brierley, David S. Cooper, Henry G. Fein, Bryan R. Haugen, Jacqueline Jonklaas, Paul W. Ladenson, Harry R. Maxon, Donald S.A. McLeod, Douglas S. Ross, Monica C. Skarulis, David L. Steward	2020	14
2	Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis Thyroid ·Donald S.A. McLeod, David S. Cooper, Paul W. Ladenson, Kenneth B. Ain, James D. Brierley, Henry G. Fein, Bryan R. Haugen, Jacqueline Jonklaas, James A. Magner, Douglas S. Ross, Monica C. Skarulis, David L. Steward, Harry R. Maxon, Steven I. Sherman	2013	103
3	Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma Annals of Internal Medicine ·Terry Taylor, Bonny Specker, J Robbins, Matthew Sperling, Mei‐Ling Ho, Kenneth B. Ain, S. Thomas Bigos, James D. Brierley, D. James Cooper, Bryan R. Haugen, Ian Hay, Vicki Hertzberg, Ines Klein, H. O. Klein, Paul W. Ladenson, Raisuke Nishiyama, Douglas S. Ross, Steven I. Sherman, Harry R. Maxon	1998	131
4	Thyrotropin Suppression and Disease Progression in Patients with Differentiated Thyroid Cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry Thyroid ·David S. Cooper, Bonny Specker, Mona Ho, Matthew Sperling, Paul W. Ladenson, Douglas S. Ross, Kenneth B. Ain, S. Thomas Bigos, James D. Brierley, Bryan R. Haugen, Irwin Klein, Jacob Robbins, Steven I. Sherman, Terry Taylor, Harry R. Maxon	1998	239
5	Prospective multicenter study of thyroid carcinoma treatment Cancer ·(unknown), Steven I. Sherman, James D. Brierley, Matthew Sperling, Kenneth B. Ain, S. Thomas Bigos, David S. Cooper, Bryan R. Haugen, Mona Ho, Irwin Klein, Paul W. Ladenson, Jacob Robbins, Douglas S. Ross, Bonny Specker, Terry Taylor, Harry R. Maxon	1998	312
6	Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid Cancer Thyroid ·Harry R. Maxon, Stephen Thomas, Ranasinghage C. Samaratunga	1997	64
7	1-123 MIBG Scintigraphy in Adults Clinical Nuclear Medicine ·Abdelhamid H. Elgazzar, Michael J. Gelfand, Lee C. Washburn, James Clark, N. Nagaraj, Dwight D. Cummings, J P Hughes, Harry R. Maxon	1995	25
8	Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA Nuclear Medicine and Biology ·Lee C. Washburn, Danuta Biniakiewicz, Harry R. Maxon	1995	10
9	Imaging modalities in the follow-up of non-lodine avid thyroid carcinoma American Journal of Otolaryngology ·W. Mallin, Abdelhamid H. Elgazzar, Harry R. Maxon	1994	11
10	Predictive estimate of blood dose from external counting data preceding radioiodine therapy for thyroid cancer Nuclear Medicine and Biology ·Stephen Thomas, Ranasinghage C. Samaratunga, Matthew Sperling, Harry R. Maxon	1993	38
11	Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases Seminars in Nuclear Medicine ·Harry R. Maxon, Stephen R. Thomas, Vicki Hertzberg, Louis E. Schroder, Emanuela Englaro, R. C. Samaratunga, Howard I. Scher, Jonathan S. Moulton, Edward Deutsch, Karen Deutsch, Harold J. Schneider, Craig C. Williams, Gary J. Ehrhardt	1992	62
12	Safety and Efficacy of Repeated Sequential Administrations of Re-186(Sn)HEDP as Palliative Therapy for Painful Skeletal Metastases Clinical Nuclear Medicine ·Emanuela Englaro, Louis E. Schroder, Stephen Thomas, Craig C. Williams, Harry R. Maxon	1992	19
13	Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. PubMed ·Harry R. Maxon, Louis E. Schroder, Vicki Hertzberg, Stephen Thomas, Emanuela Englaro, R. C. Samaratunga, Herbert J. Smith, Jonathan S. Moulton, Craig C. Williams, Gary J. Ehrhardt	1991	128
14	Thyroid Nodularity and Chromosome Aberrations Among Women in Areas of High Background Radiation in China JNCI Journal of the National Cancer Institute ·Zhen Wang, John D. Boice, Li Wei, Gilbert W. Beebe, Yan Zha, M Kaplan, Z. Too, Harry R. Maxon, S. Zhang, Arthur B. Schneider, Bing Tan, T. A. Wesseler, Di Chen, A. G. Ershow, Ruth A. Kleinerman, L. Gayle Littlefield, Dale L. Preston	1990	69
15	Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology ·Harry R. Maxon, E. Deutsch, Sheela Thomas, Karen Libson, S J Lukes, Craig C. Williams, Sundas Ali	1988	98
16	Effect of Gut Retention on the Effective Whole Body Half-Time of Iodine-131 in Thyroid Cancer Patients Journal of Nuclear Medicine Technology ·Russell Maxon, Stephen Thomas, Harry R. Maxon	1987	1
17	Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid Cancer New England Journal of Medicine ·Harry R. Maxon, Stephen Thomas, Vicki Hertzberg, James G. Kereiakes, I‐Wen Chen, Matthew Sperling, Eugene L. Saenger	1983	337
18	Potential Errors Caused by Variable Radionuclidic Purity of Iodine-123 Journal of Nuclear Medicine Technology ·Judy A. Hughes, Craig C. Williams, Stephen R. Thomas, Harry R. Maxon, Rosemary H. Basiewicz, William J. Love	1979	2
19	Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland The American Journal of Medicine ·Harry R. Maxon, Stephen R. Thomas, Eugene L. Saenger, C. Ralph Buncher, James G. Kereiakes	1977	166
20	Procainamide Induced Systemic Lupus Erythematosus Military Medicine ·Harry R. Maxon, Douglas P. Zipes	1971	3

About Harry R. Maxon

Harry R. Maxon is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Chemical Health and Safety, Radiation and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 4.4k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (24 papers), Radiopharmaceutical Chemistry and Applications (18 papers), Radiation Dose and Imaging (13 papers), Thyroid Disorders and Treatments (13 papers), Medical Imaging Techniques and Applications (12 papers), Medical Imaging and Pathology Studies (9 papers), Bone health and treatments (7 papers) and Advanced Radiotherapy Techniques (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.0k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations), Anatomy (69 citations), Surgery (1.7k citations) and Radiation (222 citations). Harry R. Maxon has collaborated with scholars based in United States, Canada and China. Frequent co-authors include James G. Kereiakes, Howard S. Smith, Stephen Thomas, Matthew Sperling, Vicki Hertzberg, Douglas S. Ross, Bryan R. Haugen, James D. Brierley, Paul W. Ladenson and Steven I. Sherman. Their work appears in journals such as Thyroid, Radiology, Clinical Chemistry, The Journal of Clinical Endocrinology & Metabolism and Nuclear Medicine and Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact